Cirak, Y. Et Al. 2012. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. BJU International , vol.110, no.11 C .

Cirak, Y., Varol, U., ATMACA İLHAN, H., Kisim, A., Sezgin, C., Karabulut, B., ... Uzunoglu, S.(2012). Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. BJU International , vol.110, no.11 C.

Cirak, Yalcin Et Al. "Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A," BJU International , vol.110, no.11 C, 2012

Cirak, Yalcin Et Al. "Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A." BJU International , vol.110, no.11 C, 2012

Cirak, Y. Et Al. (2012) . "Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A." BJU International , vol.110, no.11 C.

@article{article, author={Yalcin Cirak Et Al. }, title={Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A}, journal={BJU International}, year=2012}